These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2361134)

  • 1. How can a catalytic lesion be offset? The energetics of two pseudorevertant triosephosphate isomerases.
    Blacklow SC; Knowles JR
    Biochemistry; 1990 May; 29(17):4099-108. PubMed ID: 2361134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural basis for pseudoreversion of the E165D lesion by the secondary S96P mutation in triosephosphate isomerase depends on the positions of active site water molecules.
    Komives EA; Lougheed JC; Liu K; Sugio S; Zhang Z; Petsko GA; Ringe D
    Biochemistry; 1995 Oct; 34(41):13612-21. PubMed ID: 7577950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of water in the catalytic efficiency of triosephosphate isomerase.
    Zhang Z; Komives EA; Sugio S; Blacklow SC; Narayana N; Xuong NH; Stock AM; Petsko GA; Ringe D
    Biochemistry; 1999 Apr; 38(14):4389-97. PubMed ID: 10194358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural basis for pseudoreversion of the H95N lesion by the secondary S96P mutation in triosephosphate isomerase.
    Komives EA; Lougheed JC; Zhang Z; Sugio S; Narayana N; Xuong NH; Petsko GA; Ringe D
    Biochemistry; 1996 Dec; 35(48):15474-84. PubMed ID: 8952501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triosephosphate isomerase: removal of a putatively electrophilic histidine residue results in a subtle change in catalytic mechanism.
    Nickbarg EB; Davenport RC; Petsko GA; Knowles JR
    Biochemistry; 1988 Aug; 27(16):5948-60. PubMed ID: 2847777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction energetics of a mutant triosephosphate isomerase in which the active-site glutamate has been changed to aspartate.
    Raines RT; Sutton EL; Straus DR; Gilbert W; Knowles JR
    Biochemistry; 1986 Nov; 25(22):7142-54. PubMed ID: 2879556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of triosephosphate isomerase with L-glyceraldehyde 3-phosphate and triose 1,2-enediol 3-phosphate.
    Richard JP
    Biochemistry; 1985 Feb; 24(4):949-53. PubMed ID: 3995002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise improvements in catalytic effectiveness: independence and interdependence in combinations of point mutations of a sluggish triosephosphate isomerase.
    Blacklow SC; Liu KD; Knowles JR
    Biochemistry; 1991 Aug; 30(34):8470-6. PubMed ID: 1883832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energetics of triosephosphate isomerase: the appearance of solvent tritium in substrate glyceraldehyde 3-phosphate and in product.
    Fletcher SJ; Herlihy JM; Albery WJ; Knowles JR
    Biochemistry; 1976 Dec; 15(25):5612-7. PubMed ID: 999835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uncatalyzed rates of enolization of dihydroxyacetone phoshate and of glyceraldehyde 3-phosphate in neutral aqueous solution. The quantitative assessment of the effectiveness of an enzyme catalyst.
    Hall A; Knowles JR
    Biochemistry; 1975 Sep; 14(19):4348-53. PubMed ID: 1182103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partition of intermediates of triosephosphate isomerase: slow conformational changes precede enolization and follow product release.
    Rose IA; Iyengar R
    Biochemistry; 1982 Mar; 21(7):1591-7. PubMed ID: 7044418
    [No Abstract]   [Full Text] [Related]  

  • 12. Energetics of triosephosphate isomerase: the appearance of solvent tritium in substrate dihydroxyacetone phosphate and in product.
    Maister SG; Pett CP; Albery WJ; Knowles JR
    Biochemistry; 1976 Dec; 15(25):5607-12. PubMed ID: 999834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of a reaction intermediate as a catalytic device: definition of the functional role of the flexible loop in triosephosphate isomerase.
    Pompliano DL; Peyman A; Knowles JR
    Biochemistry; 1990 Apr; 29(13):3186-94. PubMed ID: 2185832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triosephosphate isomerase catalysis is diffusion controlled. Appendix: Analysis of triose phosphate equilibria in aqueous solution by 31P NMR.
    Blacklow SC; Raines RT; Lim WA; Zamore PD; Knowles JR
    Biochemistry; 1988 Feb; 27(4):1158-67. PubMed ID: 3365378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetics of triosephosphate isomerase: the nature of the proton transfer between the catalytic base and solvent water.
    Fisher LM; Albery WJ; Knowles JR
    Biochemistry; 1976 Dec; 15(25):5621-6. PubMed ID: 999837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active site of triosephosphate isomerase: in vitro mutagenesis and characterization of an altered enzyme.
    Straus D; Raines R; Kawashima E; Knowles JR; Gilbert W
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2272-6. PubMed ID: 3887397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energetics of triosephosphate isomerase: deuterium isotope effects in the enzyme-catalyzed reaction.
    Leadlay PF; Albery WJ; Knowles JR
    Biochemistry; 1976 Dec; 15(25):5617-20. PubMed ID: 999836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a minimum perturbation approach to predict TIM mutant structures.
    Joseph-McCarthy D; Petsko GA; Karplus M
    Protein Eng; 1995 Nov; 8(11):1103-15. PubMed ID: 8819976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ab initio models for receptor-ligand interactions in proteins. 4. Model assembly study of the catalytic mechanism of triosephosphate isomerase.
    Peräkylä M; Pakkanen TA
    Proteins; 1996 Jun; 25(2):225-36. PubMed ID: 8811738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to confirm previous observations on triosephosphate isomerase intermediate and bound substrate complexes.
    Rose IA
    Biochemistry; 1984 Nov; 23(24):5893-4. PubMed ID: 6525338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.